|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US5391481A
(en)
|
1990-08-31 |
1995-02-21 |
The Trustees Of Columbia University |
Antibody which is directed against and inhibits collagen binding to a VLA-1 epitope and uses thereof
|
|
GB9022040D0
(en)
|
1990-10-10 |
1990-11-21 |
Biopharm Ltd |
Platelet adhesion inhibitor
|
|
US5851794A
(en)
|
1990-10-22 |
1998-12-22 |
Alfa Laval Ab |
Collagen binding protein as well as its preparation
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
EP0635029A4
(en)
|
1992-04-10 |
1996-01-24 |
Gen Hospital Corp |
MATRIX PROTEIN FROM CARTILAGE AND APPLICATION METHODS.
|
|
US5491130A
(en)
|
1992-11-10 |
1996-02-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Peptide inhibitors of fibronectin and related collagen-binding proteins
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
US6288214B1
(en)
|
1996-05-16 |
2001-09-11 |
Texas A&M University Systems |
Collagen binding protein compositions and methods of use
|
|
US6387663B1
(en)
|
1998-07-31 |
2002-05-14 |
University Of Southern California |
Targeting pharmaceutical agents to injured tissues
|
|
AU1105700A
(en)
|
1998-10-09 |
2000-05-01 |
Med Immune, Inc. |
Decorin binding proteins dbp a and b and genes encoding them
|
|
WO2000054731A2
(en)
|
1999-03-15 |
2000-09-21 |
The General Hospital Corporation |
Syndesmos and uses thereof
|
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
|
US6908994B1
(en)
|
1999-05-10 |
2005-06-21 |
The Texas A&M University System |
Collagen-binding proteins from enterococcal bacteria
|
|
AU5495500A
(en)
|
1999-06-16 |
2001-01-02 |
The Texas A & M University System |
Decorin binding protein essential peptides and methods of use
|
|
AU5622800A
(en)
|
1999-06-18 |
2001-01-09 |
Med Immune, Inc. |
Combined decorin binding protein and outer surface protein compositions and methods of use
|
|
IL150198A0
(en)
|
1999-12-15 |
2002-12-01 |
Res Dev Foundation |
Betaglycan as an inhibin receptor and uses thereof
|
|
US6777547B1
(en)
|
2000-01-31 |
2004-08-17 |
Andreas Podbielski |
Collagen-binding proteins from streptococcus pyogenes
|
|
US6517838B1
(en)
|
2000-06-16 |
2003-02-11 |
The Texas A&M University System |
Decorin binding protein essential peptides and methods of use
|
|
WO2002024223A2
(en)
|
2000-09-21 |
2002-03-28 |
The Brigham And Women's Hospital, Inc. |
Prevention and treatment of streptococcal and staphylococcal infection
|
|
EP1411118B1
(en)
|
2001-06-22 |
2008-09-03 |
Chugai Seiyaku Kabushiki Kaisha |
Cell proliferation inhibitors containing anti-glypican-3 antibody
|
|
US8192744B2
(en)
|
2002-08-26 |
2012-06-05 |
Ibcc Holding As |
Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation
|
|
US7488792B2
(en)
|
2002-08-28 |
2009-02-10 |
Burnham Institute For Medical Research |
Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
|
|
GB0406415D0
(en)
|
2004-03-22 |
2004-04-21 |
Inst Of Cancer Res The |
Materials and methods for treatment of cancer
|
|
WO2005114186A1
(ja)
|
2004-05-20 |
2005-12-01 |
Wako Pure Chemical Industries, Ltd. |
ヒアルロン酸バインディングプロテインを用いたヒアルロン酸の測定方法
|
|
JP2008502890A
(ja)
|
2004-06-18 |
2008-01-31 |
エフ．ホフマン−ラ ロシュ アーゲー |
結腸直腸癌のマーカーとしてのｃｂｐ２の使用
|
|
AU2005256113B2
(en)
|
2004-07-09 |
2011-02-10 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-glypican 3 antibody
|
|
WO2006023382A2
(en)
|
2004-08-23 |
2006-03-02 |
Albert Einstein College Of Medicine Of Yeshiva University |
Collagen vi and cancer
|
|
US20090142345A1
(en)
|
2005-03-15 |
2009-06-04 |
Takeda Pharmaceutical Company Limited |
Prophylactic/therapeutic agent for cancer
|
|
EP1896386B1
(en)
|
2005-06-08 |
2012-09-05 |
Cangene Corporation |
Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
|
|
KR101704734B1
(ko)
|
2005-07-01 |
2017-02-09 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
EP1864996A1
(en)
|
2006-06-06 |
2007-12-12 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker.
|
|
HU0600578D0
(en)
|
2006-07-13 |
2006-09-28 |
Szilak Labor Bioinformatikai E |
Nuclear protein transport
|
|
EP2058659A4
(en)
|
2006-08-08 |
2009-10-21 |
Seikagaku Kogyo Co Ltd |
PROCESS FOR DETERMINING THE MOLECULAR WEIGHT OF HYALURONIC ACID
|
|
AU2008275985B2
(en)
|
2007-07-17 |
2013-09-19 |
E. R. Squibb & Sons, L.L.C. |
Monoclonal antibodies against Glypican-3
|
|
CA2718707C
(en)
|
2008-03-17 |
2018-01-02 |
University Of Miyazaki |
Method for detection of liver cancer cell using anti-glypican-3 antibody
|
|
US20090297479A1
(en)
|
2008-03-28 |
2009-12-03 |
Kiyoshi Ariizumi |
Dc-hil conjugates for treatment of t-cell disorders
|
|
SG189730A1
(en)
|
2008-04-02 |
2013-05-31 |
Macrogenics Inc |
Her2/neu-specific antibodies and methods of using same
|
|
ES2399584T3
(es)
|
2008-04-15 |
2013-04-02 |
Wako Pure Chemical Industries, Ltd. |
Nueva proteína capaz de unirse al ácido hialurónico y procedimiento para medir el ácido hialurónico usando la misma
|
|
JP2012503203A
(ja)
|
2008-09-19 |
2012-02-02 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
基底乳癌腫の診断および処置のためのｃｓｐｇ４に対するモノクローナル抗体
|
|
GB0818273D0
(en)
|
2008-10-06 |
2008-11-12 |
Cambridge Entpr Ltd |
Modulation of cellular activity and differentiation
|
|
KR101105428B1
(ko)
|
2009-02-12 |
2012-01-17 |
경북대학교 산학협력단 |
글리피칸-3 단백질과 특이적으로 결합하는 펩타이드
|
|
WO2010129547A1
(en)
|
2009-05-04 |
2010-11-11 |
Purdue Research Foundation |
Collagen-binding synthetic peptidoglycans for wound healing
|
|
US8906649B2
(en)
|
2010-09-27 |
2014-12-09 |
Janssen Biotech, Inc. |
Antibodies binding human collagen II
|
|
BR112013008738B1
(pt)
*
|
2010-10-11 |
2017-12-19 |
Abbvie Bahamas Ltd. |
Method for purification of a protein
|
|
CA2817779C
(en)
|
2010-11-15 |
2019-02-19 |
Pieris Pharmaceuticals Gmbh |
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
|
|
CN105440123B
(zh)
*
|
2011-02-10 |
2020-10-09 |
罗切格利卡特公司 |
突变体白介素-2多肽
|
|
LT2691417T
(lt)
|
2011-03-29 |
2018-10-25 |
Roche Glycart Ag |
Antikūno fc variantai
|
|
US9206257B2
(en)
|
2011-04-19 |
2015-12-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
|
US9217016B2
(en)
|
2011-05-24 |
2015-12-22 |
Symic Ip, Llc |
Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
|
|
WO2013070468A1
(en)
|
2011-11-08 |
2013-05-16 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
EP2804586A4
(en)
|
2012-01-19 |
2016-03-16 |
Univ Johns Hopkins |
BIOMATERIALS CONTAINING HYALURONIC ACID BINDING PEPTIDES AND BIFUNCTIONAL BIOPOLYMERMOLUCKS FOR HYALURONIC ACIDIC TREATMENT AND TISSUE RENEWAL APPLICATIONS
|
|
WO2013163766A1
(en)
|
2012-05-04 |
2013-11-07 |
Cangene Corporation |
ANTIMICROBIAL COMPOSITIONS COMPRISING A HYALURONIC ACID BINDING PEPTIDE AND A β-LACTAM ANTIBIOTIC
|
|
WO2013174783A1
(en)
|
2012-05-23 |
2013-11-28 |
Pieris Ag |
Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
|
|
CN104520331B
(zh)
|
2012-06-01 |
2018-09-07 |
美国政府(由卫生和人类服务部的部长所代表) |
磷脂酰肌醇蛋白聚糖3的高亲和力单克隆抗体及其用途
|
|
US10093745B2
(en)
|
2013-05-29 |
2018-10-09 |
The Regents Of The University Of California |
Anti-CSPG4 fusions with interferon for the treatment of malignancy
|
|
US20160032007A1
(en)
|
2014-04-28 |
2016-02-04 |
Duke University |
Human Antibody Fragments Against Chondroitin Sulfate Proteoglycan 4 (CSPG4)
|
|
JP6822849B2
(ja)
|
2014-06-27 |
2021-01-27 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
多重特異的ＮＫｐ４６結合タンパク質
|
|
US10166304B2
(en)
|
2014-07-11 |
2019-01-01 |
Regents Of The University Of Minnesota |
Antibody fragments for detecting cancer and methods of use
|
|
MA40764A
(fr)
|
2014-09-26 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Agent thérapeutique induisant une cytotoxicité
|
|
EP3218413A4
(en)
|
2014-11-12 |
2018-03-28 |
Memorial Sloan-Kettering Cancer Center |
Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereof
|
|
WO2016150884A1
(en)
|
2015-03-20 |
2016-09-29 |
Orbsen Therapeutics Limited |
Modulators of syndecan-2 and uses thereof
|
|
WO2016164429A1
(en)
|
2015-04-06 |
2016-10-13 |
The General Hospital Corporation |
Anti-cspg4 chimeric antigen receptors
|
|
AU2016276981B2
(en)
*
|
2015-06-12 |
2022-10-06 |
Alector Llc |
Anti-CD33 antibodies and methods of use thereof
|
|
US11370845B2
(en)
|
2015-06-24 |
2022-06-28 |
Keio University |
Anti-glypican-1-immunizing antigen receptor
|
|
EP3349770A1
(en)
|
2015-09-14 |
2018-07-25 |
Regents of the University of Minnesota |
Nk cells exhibiting an adaptive phenotype and methods for preparing and for using
|
|
EP3353198B1
(en)
|
2015-09-23 |
2020-06-17 |
Bristol-Myers Squibb Company |
Glypican-3binding fibronectin based scafflold molecules
|
|
JP7461620B2
(ja)
|
2015-10-06 |
2024-04-04 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
治療用化合物及び方法
|
|
KR101796688B1
(ko)
|
2015-10-29 |
2017-12-01 |
재단법인 목암생명과학연구소 |
신규 항-글리피칸 3 항체 및 이를 포함하는 약학적 조성물
|
|
AU2017305170A1
(en)
|
2016-08-02 |
2019-02-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof
|
|
EP3511340B1
(en)
*
|
2016-08-10 |
2024-10-02 |
Ajou University Industry-Academic Cooperation Foundation |
Heterodimeric fc-fused cytokine and pharmaceutical composition comprising the same
|
|
MX2019004327A
(es)
*
|
2016-10-14 |
2019-10-14 |
Xencor Inc |
Proteinas de fusion heterodimericas biespecificas que contienen proteinas de fusion fc il-15/il-15ra y fragmentos de anticuerpo pd-1.
|
|
US11248022B2
(en)
|
2017-03-08 |
2022-02-15 |
The Regents Of The University Of Michigan |
Glypican-3 peptide reagents and methods
|
|
CN110691793A
(zh)
|
2017-04-26 |
2020-01-14 |
田边三菱制药株式会社 |
黏结蛋白聚糖-1（cd138）结合剂及其用
|
|
WO2018199318A1
(ja)
|
2017-04-28 |
2018-11-01 |
国立大学法人高知大学 |
抗ｇｐｃ－１抗体
|
|
WO2018208448A1
(en)
*
|
2017-05-11 |
2018-11-15 |
Emd Millipore Corporation |
Method of maintaining narrow residence time distributions in continuous flow systems
|
|
JP2020525445A
(ja)
*
|
2017-06-21 |
2020-08-27 |
セファロン・インコーポレイテッドＣｅｐｈａｌｏｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
カチオン交換クロマトグラフィーの洗浄緩衝液
|
|
RU2021110369A
(ru)
*
|
2017-09-07 |
2021-06-01 |
Драгонфлай Терапьютикс, Инк. |
Белки, связывающие nkg2d, cd16 и опухолеассоциированный антиген
|
|
MX2020008333A
(es)
|
2018-02-08 |
2020-09-21 |
Dragonfly Therapeutics Inc |
Terapia de combinacion del cancer que incluye proteinas de union multiespecificas que activan a las celulas asesinas naturales.
|
|
KR102884523B1
(ko)
*
|
2018-10-03 |
2025-11-10 |
젠코어 인코포레이티드 |
IL-12 이종이량체 Fc-융합 단백질
|
|
KR20210080460A
(ko)
*
|
2018-10-23 |
2021-06-30 |
드래곤플라이 쎄라퓨틱스, 인크. |
이종이량체성 Fc-융합된 단백질
|